Status:
COMPLETED
Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study
Lead Sponsor:
Jill Hamilton-Reeves, PhD RD LD
Collaborating Sponsors:
American Cancer Society, Inc.
Société des Produits Nestlé (SPN)
Conditions:
Bladder Cancer
Radical Cystectomy
Eligibility:
MALE
40-90 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is determine if using Impact Advanced Recovery® before and after RC surgery helps reduce surgical complications.
Detailed Description
Radical cystectomy (RC) is the removal of the entire bladder and nearby organs that may contain cancer cells. It is a major surgery that can lead to breakdown of proteins in the body and a decreased i...
Eligibility Criteria
Inclusion
- Men undergoing RC surgery for primary bladder cancer
Exclusion
- Patients with swallowing difficulties or unable to tolerate oral intake
- Evidence of metastatic disease
- Weight loss ≥ 10% (with respect to usual body weight) in the 6 months prior to surgery or BMI ≤ 18.5
- Patients undergoing cystectomy for non-bladder primary malignancy or cancer type other than urothelial
- Active viral infections such as Human immunodeficiency virus (HIV) positive, hepatitis, or who have a known immunodeficient state
- Prior history of gouty arthritis or uric acid stones
- Patients with milk, soy, or fish allergies
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01868087
Start Date
July 1 2013
End Date
March 1 2016
Last Update
November 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160